# FDA Inspection 1271571 - Bell Pharmaceuticals, Inc - June 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/1926ee2f-7dde-4b69-842d-0d7262eb1ed9
Source feed: FDA_Inspections

> FDA Inspection 1271571 for Bell Pharmaceuticals, Inc on June 18, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271571
- Company Name: Bell Pharmaceuticals, Inc
- Inspection Date: 2025-06-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Minneapolis District Office

## Related Documents

- [FDA Inspection 1047160 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/007d8ca2-c29a-4864-9c30-60730e44ee8f)
- [FDA Inspection 955992 - 2015-11-20](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/4e2cc4c3-9240-4f27-8237-477595714bf1)
- [FDA Inspection 826998 - 2013-04-05](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/9d791269-7da1-43fc-8b4d-f6c365418ff2)
- [FDA Inspection 697960 - 2010-11-12](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/11a7ca0d-1523-4833-96e9-dee74e01ae6e)
- [FDA Inspection 582576 - 2009-05-15](https://www.keypedia.com/records/fda_inspections/bell-pharmaceuticals-inc/e4f54e43-ffc6-4440-a948-f6ddf11751ae)

Company: https://www.keypedia.com/companies/bell-pharmaceuticals-inc/bb92f552-7a5a-4a84-b282-4310321b816b

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d